1. Porter, Tyrel, Kucheryavykh, Lilia. 2024. F10 Gene Expression and Ethnic Disparities Present in Papillary Thyroid Carcinoma. In Journal of personalized medicine, 14, . doi:10.3390/jpm14050524. https://pubmed.ncbi.nlm.nih.gov/38793106/
2. Heller, L, Bulysheva, A, Arpag, S, Heller, R, Cemazar, M. 2021. Growth environment influences B16.F10 mouse melanoma cell response to gene electrotransfer. In Bioelectrochemistry (Amsterdam, Netherlands), 140, 107827. doi:10.1016/j.bioelechem.2021.107827. https://pubmed.ncbi.nlm.nih.gov/33971375/
3. Liu, Xiaoping, Tang, Hailin, Wang, Zeyou, Wu, Minghua, Li, Guiyuan. 2011. F10 gene hypomethylation, a putative biomarker for glioma prognosis. In Journal of neuro-oncology, 107, 479-85. doi:10.1007/s11060-011-0775-2. https://pubmed.ncbi.nlm.nih.gov/22160665/
4. Menegatti, Marzia, Peyvandi, Flora. 2009. Factor X deficiency. In Seminars in thrombosis and hemostasis, 35, 407-15. doi:10.1055/s-0029-1225763. https://pubmed.ncbi.nlm.nih.gov/19598069/
5. Song, Yali, Cao, Wei, Zhu, Xi, Yuan, Weizhuang, Quan, Song. 2017. F10, a novel hydatidiform mole-associated gene, inhibits the paclitaxel sensitivity of A549 lung cancer cells by downregulating BAX and caspase-3. In Oncology letters, 13, 2563-2568. doi:10.3892/ol.2017.5749. https://pubmed.ncbi.nlm.nih.gov/28454434/